To increase the phenotypic (and presumably genotypic) diversity for studying the effect of genetic modulators of L2-PD, we recruited three non-manifesting carriers of the LRRK2 G2019S mutation (L2-NMC). The gene discussed is LRRK2; the disease is Parkinson disease.